SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 24.39-0.2%Nov 10 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: manny t who wrote (7878)6/11/1999 11:01:00 AM
From: Anthony Wong  Read Replies (1) of 9523
 
This Everen analyst has a price target of $149 (ST) and $165 (LT)::

Pfizer Inc. Reiterated Short-Term 'Outperform' at Everen

Bloomberg News
June 11, 1999, 9:56 a.m. ET

Princeton, New Jersey, June 11 (Bloomberg Data) -- Pfizer Inc. (PFE US)
was reiterated short-term ''outperform'' by analyst Jeffrey J. Kraws at Everen
Securities. The long-term rating was also reiterated ''outperform.'' The
near-term and long- term price targets were also reiterated at $149 and $165,
respectively.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext